Cooper Companies, Inc. (COO) stock
COONasdaqOphthalmic GoodsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 9, 2026Score 16/3040% below fair value
$60.72−1.16 (-1.87%)
Close on Nov 17, 2026Market cap $11.55BP/E 20.7Yield –
Cooper Companies r&d expenses
Research and development expenses are spending on new products and technology.
Cooper Companies's R&D Expenses for the twelve months ending Jul 31, 2026 was $169.80M, up 0.8% year over year. For fiscal 2025 it was $172.20M, up 11.0% from the year before. Over ten years it grew 9.5% a year on average. The highest annual figure on record is $172.20M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Oct 31, 2025 | $172.20M | +11.0% |
| FY2024 | Oct 31, 2024 | $155.10M | +12.9% |
| FY2023 | Oct 31, 2023 | $137.40M | +24.6% |
| FY2022 | Oct 31, 2022 | $110.30M | +19.0% |
| FY2021 | Oct 31, 2021 | $92.70M | -0.6% |
| FY2020 | Oct 31, 2020 | $93.30M | +7.6% |
| FY2019 | Oct 31, 2019 | $86.70M | +2.2% |
| FY2018 | Oct 31, 2018 | $84.80M | +22.5% |
| FY2017 | Oct 31, 2017 | $69.20M | +5.8% |
| FY2016 | Oct 31, 2016 | $65.40M | -6.0% |
| FY2015 | Oct 31, 2015 | $69.60M | +5.0% |
| FY2014 | Oct 31, 2014 | $66.26M | +12.6% |
| FY2013 | Oct 31, 2013 | $58.83M | +13.7% |
| FY2012 | Oct 31, 2012 | $51.73M | +18.7% |
| FY2011 | Oct 31, 2011 | $43.58M | +23.5% |
| FY2010 | Oct 31, 2010 | $35.27M | +5.9% |
| FY2009 | Oct 31, 2009 | $33.30M | -6.1% |
| FY2008 | Oct 31, 2008 | $35.47M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jul 31, 2026 | $41.60M | -6.7% |
| Q2 FY2026CQ1 2026 | Apr 30, 2026 | $42.50M | -6.6% |
| Q1 FY2026CQ4 2025 | Jan 31, 2026 | $44.30M | +8.8% |
| Q4 FY2025CQ3 2025 | Oct 31, 2025 | $41.40M | +9.8% |
| Q3 FY2025CQ2 2025 | Jul 31, 2025 | $44.60M | +14.4% |
| Q2 FY2025CQ1 2025 | Apr 30, 2025 | $45.50M | +17.0% |
| Q1 FY2025CQ4 2024 | Jan 31, 2025 | $40.70M | +3.0% |
| Q4 FY2024CQ3 2024 | Oct 31, 2024 | $37.70M | +2.7% |
| Q3 FY2024CQ2 2024 | Jul 31, 2024 | $39.00M | +6.8% |
| Q2 FY2024CQ1 2024 | Apr 30, 2024 | $38.90M | +19.3% |
| Q1 FY2024CQ4 2023 | Jan 31, 2024 | $39.50M | +25.0% |
| Q4 FY2023CQ3 2023 | Oct 31, 2023 | $36.70M | +26.1% |
| Q3 FY2023CQ2 2023 | Jul 31, 2023 | $36.50M | +27.2% |
| Q2 FY2023CQ1 2023 | Apr 30, 2023 | $32.60M | +24.0% |
| Q1 FY2023CQ4 2022 | Jan 31, 2023 | $31.60M | +20.6% |
| Q4 FY2022CQ3 2022 | Oct 31, 2022 | $29.10M | +13.2% |
| Q3 FY2022CQ2 2022 | Jul 31, 2022 | $28.70M | +15.7% |
| Q2 FY2022CQ1 2022 | Apr 30, 2022 | $26.30M | +25.2% |
| Q1 FY2022CQ4 2021 | Jan 31, 2022 | $26.20M | +22.4% |
| Q4 FY2021CQ3 2021 | Oct 31, 2021 | $25.70M | +0.8% |
| Q3 FY2021CQ2 2021 | Jul 31, 2021 | $24.80M | +13.8% |
| Q2 FY2021CQ1 2021 | Apr 30, 2021 | $21.00M | -11.8% |
| Q1 FY2021CQ4 2020 | Jan 31, 2021 | $21.40M | -3.6% |
| Q4 FY2020CQ3 2020 | Oct 31, 2020 | $25.50M | +9.4% |
| Q3 FY2020CQ2 2020 | Jul 31, 2020 | $21.80M | +1.4% |
| Q2 FY2020CQ1 2020 | Apr 30, 2020 | $23.80M | +13.3% |
| Q1 FY2020CQ4 2019 | Jan 31, 2020 | $22.20M | +5.7% |
| Q4 FY2019CQ3 2019 | Oct 31, 2019 | $23.30M | +3.1% |
| Q3 FY2019CQ2 2019 | Jul 31, 2019 | $21.50M | -4.4% |
| Q2 FY2019CQ1 2019 | Apr 30, 2019 | $21.00M | +1.0% |
| Q1 FY2019CQ4 2018 | Jan 31, 2019 | $21.00M | +11.7% |
| Q4 FY2018CQ3 2018 | Oct 31, 2018 | $22.60M | +21.5% |
| Q3 FY2018CQ2 2018 | Jul 31, 2018 | $22.50M | +28.6% |
| Q2 FY2018CQ1 2018 | Apr 30, 2018 | $20.80M | +23.8% |
| Q1 FY2018CQ4 2017 | Jan 31, 2018 | $18.80M | +15.3% |
| Q4 FY2017CQ3 2017 | Oct 31, 2017 | $18.60M | +3.3% |
| Q3 FY2017CQ2 2017 | Jul 31, 2017 | $17.50M | – |
| Q2 FY2017CQ1 2017 | Apr 30, 2017 | $16.80M | – |
| Q1 FY2017CQ4 2016 | Jan 31, 2017 | $16.30M | – |
| Q4 FY2016CQ3 2016 | Oct 31, 2016 | $18.00M | – |
See a number that looks wrong?